跳转至内容
Merck
CN

V900753

柠檬酸三乙酯

Vetec, reagent grade, 98%

别名:

柠檬酸乙酯

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
HOC(COOC2H5)(CH2COOC2H5)2
化学文摘社编号:
分子量:
276.28
EC Number:
201-070-7
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
1801199
MDL number:
Assay:
98%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

reagent grade

vapor density

9.7 (vs air)

vapor pressure

1 mmHg ( 107 °C)

product line

Vetec

assay

98%

refractive index

n20/D 1.442 (lit.)

bp

235 °C/150 mmHg (lit.)

density

1.14 g/mL at 25 °C (lit.)

SMILES string

CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC

InChI

1S/C12H20O7/c1-4-17-9(13)7-12(16,11(15)19-6-3)8-10(14)18-5-2/h16H,4-8H2,1-3H3

InChI key

DOOTYTYQINUNNV-UHFFFAOYSA-N

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under 柠檬酸三乙酯


存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



T Quinten et al.
AAPS PharmSciTech, 13(4), 1197-1211 (2012-09-12)
Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding. The influence of process temperature; matrix composition; drug load, plasticizer level; and salt form of metoprolol: tartrate (MPT), fumarate (MPF) and succinate (MPS) on ease of
Shital M Maru et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 44(4), 471-478 (2011-09-20)
The influence of antiretroviral drugs and plasticizers on the rheological and thermal characteristics of ethyl cellulose formulations intended for hot melt extrusion has been investigated. Antiretroviral drugs used were zidovudine and lamivudine, whilst plasticizers included triethylcitrate (TEC) and polyethylene glycol
Ravikumar R Patel et al.
Acta pharmaceutica (Zagreb, Croatia), 61(1), 73-82 (2011-03-17)
In situ forming intragastric controlled-release formulation is a new technology in the field of oral controlled-release delivery systems. The objective of this study was to develop formulations that can control drug release up to 24 hours. In addition, a combination



全球贸易项目编号

货号GTIN
V900753-250ML04061836697082
V900753-1L04061836697075